XML 90 R84.htm IDEA: XBRL DOCUMENT v2.4.0.6
Guarantor and Non-Guarantor Financial Statements - Schedule of Condensed Statements of Operations and Comprehensive Income (Loss) (Detail) (USD $)
In Millions, unless otherwise specified
3 Months Ended 9 Months Ended 12 Months Ended
May 31, 2012
Feb. 29, 2012
Nov. 30, 2011
Aug. 31, 2011
May 31, 2011
Feb. 28, 2011
Nov. 30, 2010
Aug. 31, 2010
Feb. 28, 2013
Feb. 29, 2012
May 31, 2012
May 31, 2011
May 31, 2010
Schedule Of Condensed Statements Of Operations [Line Items]                          
Net sales $ 739.5 $ 708.9 $ 725.1 $ 664.6 $ 715.2 $ 678.0 $ 698.3 $ 640.7 $ 2,269.0 $ 2,098.6 $ 2,838.1 $ 2,732.2 [1] $ 2,698.0 [1],[2]
Cost of sales                 736.0 669.9 894.4 838.7 819.9
Gross profit 515.0 489.2 490.2 449.3 486.1 469.9 490.8 446.7 1,533.0 1,428.7 1,943.7 1,893.5 1,878.1
Goodwill and intangible asset impairment charge 529.8               334.1 0 [3] 529.8 941.4 [3] 0 [3]
Operating expenses                 1,224.1 1,144.1 1,507.3 1,529.0 1,521.5
Operating income (loss)                 (25.2) 284.6 (93.4) (576.9) 356.6
Other (income) expense, net                 483.2 372.7 497.4 487.7 498.3
Loss before income taxes                 (508.4) (88.1) (590.8) (1,064.6) (141.7)
Tax expense (benefit)                 (106.2) (18.4) (132.0) (214.8) (94.1)
Equity in earnings of subsidiaries                 0 0 0 0 0
Net loss (389.1) (16.5) (14.0) (39.2) (812.8) (11.6) (7.6) (17.8) (402.2) (69.7) [3] (458.8) (849.8) [3] (47.6) [3]
Other comprehensive income (loss)                 (46.7) (5.3) (48.9) 282.4 (79.9)
Comprehensive loss                 (448.9) (75.0) (507.7) (567.4) (127.5)
Biomet, Inc. [Member]
                         
Schedule Of Condensed Statements Of Operations [Line Items]                          
Net sales                 0 0 0 0 0
Cost of sales                 0 0 0 0 0
Gross profit                 0 0 0 0 0
Goodwill and intangible asset impairment charge                 0   0 0  
Operating expenses                 0 0 0 0 0
Operating income (loss)                 0 0 0 0 0
Other (income) expense, net                 479.0 360.6 477.1 493.9 514.1
Loss before income taxes                 (479.0) (360.6) (477.1) (493.9) (514.1)
Tax expense (benefit)                 (182.0) (115.1) (181.3) (187.2) (200.5)
Equity in earnings of subsidiaries                 (105.2) 175.8 (163.0) (543.1) 266.0
Net loss                 (402.2) (69.7) (458.8) (849.8) (47.6)
Other comprehensive income (loss)                 5.9 17.4 13.1 19.5 11.3
Comprehensive loss                 (396.3) (52.3) (445.7) (830.3) (36.3)
Guarantors [Member]
                         
Schedule Of Condensed Statements Of Operations [Line Items]                          
Net sales                 1,438.6 1,316.1 1,769.8 1,716.5 1,710.4
Cost of sales                 551.1 368.7 491.9 399.7 405.2
Gross profit                 887.5 947.4 1,277.9 1,316.8 1,305.2
Goodwill and intangible asset impairment charge                 269.0   264.3 0  
Operating expenses                 908.3 763.4 1,023.7 1,002.3 996.4
Operating income (loss)                 (289.8) 184.0 (10.1) 314.5 308.8
Other (income) expense, net                 5.1 1.5 3.1 (9.8) (4.0)
Loss before income taxes                 (294.9) 182.5 (13.2) 324.3 312.8
Tax expense (benefit)                 (112.1) 69.3 86.8 101.0 98.5
Equity in earnings of subsidiaries                 0 0 0 0 0
Net loss                 (182.8) 113.2 (100.0) 223.3 214.3
Other comprehensive income (loss)                 0 0 0 (4.0) 1.8
Comprehensive loss                 (182.8) 113.2 (100.0) 219.3 216.1
Non-Guarantors [Member]
                         
Schedule Of Condensed Statements Of Operations [Line Items]                          
Net sales                 830.4 782.5 1,068.3 1,015.7 987.6
Cost of sales                 184.9 301.2 402.5 439.0 414.7
Gross profit                 645.5 481.3 665.8 576.7 572.9
Goodwill and intangible asset impairment charge                 65.1   265.5 941.4  
Operating expenses                 315.8 380.7 483.6 526.7 525.1
Operating income (loss)                 264.6 100.6 (83.3) (891.4) 47.8
Other (income) expense, net                 (0.9) 10.6 17.2 3.6 (11.8)
Loss before income taxes                 265.5 90.0 (100.5) (895.0) 59.6
Tax expense (benefit)                 187.9 27.4 (37.5) (128.6) 7.9
Equity in earnings of subsidiaries                 0 0 0 0 0
Net loss                 77.6 62.6 (63.0) (766.4) 51.7
Other comprehensive income (loss)                 (52.6) (22.7) (62.0) 266.9 (93.0)
Comprehensive loss                 25.0 39.9 (125.0) (499.5) (41.3)
Eliminations [Member]
                         
Schedule Of Condensed Statements Of Operations [Line Items]                          
Net sales                 0 0 0 0 0
Cost of sales                 0 0 0 0 0
Gross profit                 0 0 0 0 0
Goodwill and intangible asset impairment charge                 0   0 0  
Operating expenses                 0 0 0 0 0
Operating income (loss)                 0 0 0 0 0
Other (income) expense, net                 0 0 0 0 0
Loss before income taxes                 0 0 0 0 0
Tax expense (benefit)                 0 0 0 0 0
Equity in earnings of subsidiaries                 105.2 (175.8) 163.0 543.1 (266.0)
Net loss                 105.2 (175.8) 163.0 543.1 (266.0)
Other comprehensive income (loss)                 0 0 0 0 0
Comprehensive loss                 $ 105.2 $ (175.8) $ 163.0 $ 543.1 $ (266.0)
[1] New product categories were adopted in order to more closely represent the way the Company reports sales and markets products. Certain amounts have been reclassified to conform to the current presentation.
[2] Certain amounts have been adjusted to conform to the current presentation. Specifically, International net sales increased, and Europe net sales decreased, $4.3 million for the year ended May 31, 2010. The current presentation aligns with how the Company presently manages and markets its products.
[3] Certain amounts have been adjusted to conform to the current presentation.